Pura Vida Investments
41
117M
28
3.42
1
0.32
9
- Stages of investment
- Areas of investment
Summary
In 2012 was created Pura Vida Investments, which is appeared as VC. The main office of represented VC is situated in the New York. The company was established in North America in United States.
The high activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations.
Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Acutus Medical, MedAvail, V-Wave. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Pura Vida Investments, startups are often financed by Pontifax, OrbiMed, GE Ventures. The meaningful sponsors for the fund in investment in the same round are Triventures, Redmile Group, Pontifax. In the next rounds fund is usually obtained by Deerfield Capital Management, Triventures, Royalties Fund.
Investments analytics
Analytics
- Total investments
- 41
- Lead investments
- 1
- Exits
- 9
- Rounds per year
- 3.42
- Follow on index
- 0.32
- Investments by industry
- Health Care (30)
- Biotechnology (29)
- Medical (17)
- Medical Device (14)
- Health Diagnostics (10) Show 27 more
- Investments by region
-
- United States (26)
- Israel (5)
- Germany (4)
- Canada (5)
- Netherlands (1)
- Peak activity year
- 2021
- Number of Unicorns
- 3
- Number of Decacorns
- 3
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 363M
- Group Appearance index
- 1.00
- Avg. company exit year
- 2
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Alamar Biosciences | 26 Feb 2024 | Biotechnology, Health Care, Medical | Late Stage Venture | 128M | United States, California, Hayward |
| PerimeterX | 21 Jan 2015 | Network Security, Security, Computer | Seed | 2M | United States, California |
| Vizgen | 07 Apr 2021 | Biotechnology | Early Stage Venture | 37M | United States, Massachusetts, Cambridge |
| WSO2 | 12 May 2011 | Software, Information Technology, Enterprise Software, Open Source | Early Stage Venture | 6M | United States, California, Mountain View |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.